Erratum: The evidence of glioblastoma heterogeneity (Scientific Reports (2014) 4 : 7979 DOI: 10.1038/srep07979);The evidence of glioblastoma heterogeneity

Scientific Reports

Volumn 5, Issue , 2015, Pages 7979-

  Soeda, Akio ^a   Hara, Akira ^a   Kunisada, Takahiro ^a   Yoshimura, Shin Ichi ^a   Iwama, Toru ^a   Park, Deric M ^b  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE I, ALPHA 1 CHAIN; EPIDERMAL GROWTH FACTOR RECEPTOR; GEFITINIB; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-RELATED PROTEIN 1; LEUKOCYTE ANTIGEN; PROTEIN KINASE INHIBITOR; QUINAZOLINE DERIVATIVE; SOMATOMEDIN BINDING PROTEIN;

ANIMAL; ANTAGONISTS AND INHIBITORS; BRAIN TUMOR; DISEASE MODEL; DNA MICROARRAY; DRUG EFFECTS; GLIOBLASTOMA; HUMAN; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; MORTALITY; MOUSE; NONOBESE DIABETIC MOUSE; PATHOLOGY; SCID MOUSE; SIGNAL TRANSDUCTION; TUMOR CELL CULTURE; XENOGRAFT;

ANIMALS; ANTIGENS, CD; BRAIN NEOPLASMS; COLLAGEN TYPE I; DISEASE MODELS, ANIMAL; GLIOBLASTOMA; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; KAPLAN-MEIER ESTIMATE; MICE; MICE, INBRED NOD; MICE, SCID; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN KINASE INHIBITORS; QUINAZOLINES; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 84923009317     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep09630     Document Type: Erratum

References (22)

1. Stupp, R. et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352, 987-996 (2005).
2. Kleihues, P. et al. The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 61, 215-225 (2002).
3. Venere, M., Fine, H. A., Dirks, P. B. & Rich, J. N. Cancer stem cells in gliomas: identifying and understanding the apex cell in cancer's hierarchy. Glia 59, 1148-1154 (2011).
4. Singh, S. K. et al. Identification of human brain tumour initiating cells. Nature 432, 396-401 (2004).
5. Park, D. M. & Rich, J. N. Biology of glioma cancer stem cells. Mol Cells 28, 7-12 (2009).
6. Soeda, A. et al. Epidermal growth factor plays a crucial role in mitogenic regulation of human brain tumor stem cells. J Biol Chem 283, 10958-10966 (2008).
7. Bao, S. et al. Targeting cancer stem cells through L1CAM suppresses glioma growth. Cancer Res 68, 6043-6048 (2008).
8. Inagaki, A. et al. Long-term maintenance of brain tumor stem cell properties under at non-adherent and adherent culture conditions. Biochem Biophys Res Commun 361, 586-592 (2007).
9. Bao, S. et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444, 756-760 (2006).
10. Dandy, W. E. Removal of right cerebral hemisphere for certain tumors with hemiplegia: Preliminary report. JAMA 90, 823-825 (1928).
11. Soeda, A., Ohe, N., Lee, D., Iwama, T. & Park, M. D. Surface protein dynamics in glioma stem cells. Austin J Neurosurg 1, 7-13 (2014).
12. Phillips, T. M., McBride, W. H. & Pajonk, F. The response of CD24(-/low)/CD441 breast cancer-initiating cells to radiation. J Natl Cancer Inst 98, 1777-1785 (2006).
13. Todaro, L. et al. Alteration of serum and tumoral neural cell adhesion molecule (NCAM) isoforms in patients with brain tumors. J Neurooncol 83, 135-144 (2007).
14. Wang, Q., Pfeiffer, G. R., 2nd & Gaarde, W. A. Activation of SRC tyrosine kinases in response to ICAM-1 ligation in pulmonary microvascular endothelial cells. J Biol Chem 278, 47731-47743 (2003).
15. Larochelle, C. et al. Melanoma cell adhesion molecule identifies encephalitogenic T lymphocytes and promotes their recruitment to the central nervous system. Brain 135, 2906-2924 (2012).
16. Kijima, N. et al. CD166/activated leukocyte cell adhesion molecule is expressed on glioblastoma progenitor cells and involved in the regulation of tumor cell invasion. Neuro Oncol 14, 1254-1264 (2012).
17. Mellinghoff, I. K. et al.Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors. N Engl J Med 353, 2012-2024 (2005).
18. Dziembowska, M. et al . A role for CXCR4 signaling in survival and migration of neural and oligodendrocyte precursors. Glia 50, 258-269 (2005).
19. Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455, 1061-1068 (2008).
20. Payne, L. S. & Huang, P. H. The pathobiology of collagens in glioma. Mol Cancer Res 11, 1129-1140 (2013).
21. Tomimaru, Y. et al. IGFBP7 downregulation is associated with tumor progression and clinical outcome in hepatocellular carcinoma. Int J Cancer 130, 319-327 (2012).
22. Patel, A. P. et al . Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science 344, 1396-1401 (2014).